The University Clinical Centre of Serbia is an academic health science centre located in Belgrade, Serbia. It serves as the main medical centre for both Belgrade and the rest of Serbia.

There are 3,150 (2017) beds in Clinical Center Of Serbia, Clinic of Urology.

During the past decade, Clinical Center Of Serbia, Clinic of Urology conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 11 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Center Of Serbia, Clinic of Urology" #1 sponsor was "ACADIA Pharmaceuticals Inc." with 5 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Sunovion" with 4 trials sponsored, "Clinical Centre of Serbia" with 2 trials sponsored and "United Therapeutics" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Center Of Serbia, Clinic of Urology" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Clinical Centre of Kragujevac" with 1 trials as a collaborator, "Clinical Hopital Center Zemun" with 1 trials as a collaborator and "Clinical Hospital Center Zvezdara" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Center Of Serbia, Clinic of Urology" are "Bladder Cancer" (3 trials), "Urothelial Carcinoma" (3 trials), "Adjunctive Treatment of Major Depressive Disorder" (2 trials), "Atrial Fibrillation" (2 trials) and "Cardiovascular Diseases" (2 trials). Many other conditions were trialed in "Clinical Center Of Serbia, Clinic of Urology" in a lesser frequency.

Most popular intervention types in "Clinical Center Of Serbia, Clinic of Urology" are "Drug" (24 trials), "Procedure" (6 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Pimavanserin" (4 trials), "Atezolizumab" (2 trials), "Clopidogrel" (2 trials) and "Ralinepag" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Center Of Serbia, Clinic of Urology" are 28 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Center Of Serbia, Clinic of Urology". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in Clinical Center Of Serbia, Clinic of Urology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Center Of Serbia, Clinic of Urology, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".